Company Filing History:
25 out of 43 
3 out of 10 
1 out of 10 
Years Active: 2012-2024
Title: Innovations and Contributions of Xingzhou Li in Pharmaceutical Patents
Introduction
Xingzhou Li is a distinguished inventor based in Beijing, China, known for his significant contributions to the field of pharmaceutical innovation. With a remarkable portfolio of 32 patents, he has made strides in developing novel compounds and methodologies aimed at tackling pressing health challenges.
Latest Patents
Among Xingzhou Li's latest patents are pivotal advancements targeting drug resistance in tumors and infections. One patent focuses on a linker containing arylnitro and an antibody-drug conjugate, providing a new avenue for treatment and prevention of various diseases. This invention not only enhances the efficacy of drugs but also demonstrates promising applications in clinical settings.
Another notable patent pertains to a piperidine carboxamide compound, its preparation method, and diverse usages. This compound addresses the complex issues posed by drug-resistant tumors and bacteria, and introduces strategies for treating complications arising from neurodegenerative diseases and transplantation rejections. The innovation aims to leverage the effectiveness of heat shock protein 70 (Hsp70) in combating these conditions and presents a significant breakthrough in medicinal chemistry.
Career Highlights
Xingzhou Li has held esteemed positions at several reputable institutions, most notably at the Institute of Pharmacology and Toxicology, Academy of Military Medical Sciences, and Beijing Molecule Science and Technology Co., Ltd. His work in these organizations has propelled advancements in drug development and toxicology, marking him as a significant figure in pharmaceutical research.
Collaborations
Throughout his career, Xingzhou Li has collaborated with notable colleagues, including Wu Zhong and Song Li. These partnerships have facilitated the exchange of ideas and fostered a collaborative environment conducive to innovation in the rapidly evolving world of pharmaceuticals.
Conclusion
With a robust patent portfolio and a commitment to addressing significant medical challenges, Xingzhou Li continues to be a leading force in pharmaceutical innovation. His inventions not only contribute to the advancement of medical science but also provide new strategies for treating complex diseases, highlighting his impactful role in the industry.